(Q39502690)

12 September 2017

Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression (English)

1 reference

(S)-(−)-carbidopa monohydrate

12 September 2017

1 reference

1 reference

1 reference

Latif A Wafa

1

1 reference

12 September 2017

Helen Cheng

2

1 reference

12 September 2017

Nathan Plaa

3

1 reference

12 September 2017

Fariba Ghaidi

4

1 reference

12 September 2017

Takahiro Fukumoto

5

1 reference

12 September 2017

Ladan Fazli

6

1 reference

12 September 2017

Martin E Gleave

7

1 reference

12 September 2017

Michael E Cox

8

1 reference

12 September 2017

Paul S Rennie

9

1 reference

12 September 2017

language of work or name

English

0 references

publication date

14 September 2011

1 reference

International Journal of Cancer

12 September 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 September 2017

130

1 reference

12 September 2017

12

1 reference

12 September 2017

2835-2844

1 reference

Global patterns of cancer incidence and mortality rates and trends

12 September 2017

1 reference

21 January 2018

Cancer statistics, 2007

1 reference

Intermittent androgen suppression for prostate cancer: rationale and clinical experience

21 January 2018

1 reference

Future directions in the treatment of androgen-independent prostate cancer

21 January 2018

1 reference

Molecular regulation of androgen action in prostate cancer

21 January 2018

1 reference

Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex

21 January 2018

1 reference

Androgen receptor and growth factor signaling cross-talk in prostate cancer cells

21 January 2018

1 reference

Androgen receptor coregulators and their involvement in the development and progression of prostate cancer.

21 January 2018

1 reference

Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system

21 January 2018

1 reference

Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer

21 January 2018

1 reference

Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells

21 January 2018

1 reference

Use of tumor-specific gene expression for the differential diagnosis of neuroblastoma from other pediatric small round-cell malignancies

21 January 2018

1 reference

Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors: immunohistochemical study and gene expression analysis.

21 January 2018

1 reference

Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma

21 January 2018

1 reference

Aromatic L-amino acid decarboxylase: biological characterization and functional role.

21 January 2018

1 reference

Effects of L-DOPA/carbidopa administration on the levels of L-DOPA, other amino acids and related compounds in the plasma, brain and heart of the rat.

21 January 2018

1 reference

Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression

21 January 2018

1 reference

In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors.

21 January 2018

1 reference

A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.

21 January 2018

1 reference

Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene

21 January 2018

1 reference

Androgen modulation of coregulator expression in prostate cancer cells.

21 January 2018

1 reference

Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity

21 January 2018

1 reference

Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers

21 January 2018

1 reference

Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer

21 January 2018

1 reference

Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.

21 January 2018

1 reference

Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells

21 January 2018

1 reference

Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.

21 January 2018

1 reference

Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.

21 January 2018

1 reference

Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26287

1 reference

12 September 2017

1 reference